Etanercept for the management of oral lichen planus

被引:37
作者
Yarom, Noam [1 ]
机构
[1] Chaim Sheba Med Ctr, Dept Oral & Maxillofacial Surg, Oral Med Clin, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sch Dent Med, Dept Oral Pathol & Oral Med, IL-69978 Tel Aviv, Israel
关键词
Etanercept; Psoriatic Arthritis; Systemic Corticosteroid; Tumor Necrosis Factor Receptor; Juvenile Rheumatoid Arthritis;
D O I
10.2165/00128071-200708020-00010
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:121 / 121
页数:1
相关论文
共 5 条
[1]   Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease [J].
Chiang, KY ;
Abhyankar, S ;
Bridges, K ;
Godder, K ;
Henslee-Downey, PJ .
TRANSPLANTATION, 2002, 73 (04) :665-667
[2]  
Maender Jennifer L, 2005, J Drugs Dermatol, V4, P86
[3]   Recalcitrant, recurrent aphthous stomatitis treated with etanercept [J].
Robinson, ND ;
Guitart, J .
ARCHIVES OF DERMATOLOGY, 2003, 139 (10) :1259-1262
[4]  
Spencer-Green G, 2000, ANN RHEUM DIS, V59, P46
[5]   The pathogenesis of oral lichen planus [J].
Sugerman, PB ;
Savage, NW ;
Walsh, LJ ;
Zhao, ZZ ;
Zhou, XJ ;
Khan, A ;
Seymour, GJ ;
Bigby, M .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 2002, 13 (04) :350-365